The Amerlex'" free-T, RIA kit utilises an antibody suspension which contains antibody bound to polymer particles of uniform diameter. Separation of the antibody-bound fraction is effected by centrifugation of the Amerlexf suspension and decantation of the supernatant. Good separation of the fractions therefore depends upon the formation of pellets which remain intact during the decantation procedure; but we have experienced a tendency for pellets to disintegrate during decantation, leading to a loss of particles down the tube walls. We have investigated the addition of PEG 6000 following the incubation period and prior to centrifugation in an attempt to produce pellets which are less susceptible to disruption during decantation.
Amerlex" free-T4 RIA kits and Arnersharn'" thyroid control serum (Radioassay Controls 1, 2 and 3) were obtained from Amersham International, Amersham, Bucks. PEG (approx. molecular weight 6000) was obtained from Sigma London Chemical Company Ltd, Fancy Road, Poole, Dorset. The assay was carried out according to three different protocols.
(A) Strictly in accordance with the manufacturer's instructions.
(B) As A, but with the following modifications: 40 J.lL of standard, control or test and 200 !!L of 125I-thyroxine analogue were added to the assay tubes, followed by 200 J.lL of Amerlex antibody suspension. After incubation at 37°C for 1 hour, 0·8 mL of a 20% solution of PEG 6000 in normal saline was added to the tubes, followed by thorough mixing prior to centrifugation. The supernatant was removed by aspiration.
(C) As B, but with the addition of 0·8 mL of normal saline in place of the 20% solution of PEG 6000 in normal saline.
Results
Within-batch precision was calculated for ten 444 replicates of each of the three Amersham thyroid control sera (Radioassay Controls 1, 2 . and 3) assayed in a single batch; and betweenbatch variability for protocol B was calculated from the mean of duplicates of each of the three controls, assayed in fourteen different batches over 2 months. The results are presented in Table 1 .
The accuracy and precision of protocol B has been assessed by performance in the United Kingdom External Quality Assessment Scheme for Free Thyroxine. Over 6 months the assay exhibited a slight negative bias (less than 10%) and variability of the bias was less than 15%.
Discussion
The addition of PEG to the assay system causes precipitation of part of the globulin fraction of serum. On centrifugation, this precipitate together with the Arnerlexf particles forms a cohesive pellet from which the supernatant can readily be removed. The modified assay, protocol B, is reliable and robust and exhibits improved precision, attributable to the addition of PEG 6000, when compared with the manufacturer's recommended 'Procedure. Furthermore, because smaller volumes of each reagent are used, a 2·5-fold increase is achieved in the number of assay tubes which can be obtained from a kit. Preliminary experimentation with the Amerlex'" free-T, RIA kit suggests that the performance of this kit also may be improved by a similar modification.
